$HSTM
HealthStream Inc

2016 Q1 Form 10-Q Financial Statement

#000119312516572585 Filed on May 02, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $54.08M $47.16M
YoY Change 14.68% 22.96%
Cost Of Revenue $22.90M $20.19M
YoY Change 13.41% 19.3%
Gross Profit $31.18M $26.96M
YoY Change 15.63% 25.85%
Gross Profit Margin 57.65% 57.18%
Selling, General & Admin $16.53M $14.27M
YoY Change 15.8% 17.2%
% of Gross Profit 53.02% 52.94%
Research & Development $7.018M $4.646M
YoY Change 51.05% 31.02%
% of Gross Profit 22.51% 17.23%
Depreciation & Amortization $5.140M $3.253M
YoY Change 58.01% 35.49%
% of Gross Profit 16.49% 12.06%
Operating Expenses $7.018M $18.92M
YoY Change -62.91% 20.32%
Operating Profit $2.487M $4.790M
YoY Change -48.08% 45.24%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $18.00K $9.000K
YoY Change 100.0% -80.0%
Pretax Income $2.505M $4.799M
YoY Change -47.8% 43.55%
Income Tax $1.004M $2.077M
% Of Pretax Income 40.08% 43.28%
Net Earnings $1.501M $2.722M
YoY Change -44.86% 39.73%
Net Earnings / Revenue 2.78% 5.77%
Basic Earnings Per Share $0.05 $0.10
Diluted Earnings Per Share $0.05 $0.10
COMMON SHARES
Basic Shares Outstanding 31.67M shares 27.70M shares
Diluted Shares Outstanding 31.97M shares 28.07M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.5M $64.40M
YoY Change 133.7% -36.86%
Cash & Equivalents $82.79M $34.76M
Short-Term Investments $67.70M $29.60M
Other Short-Term Assets $6.371M $5.780M
YoY Change 10.22% 78.89%
Inventory
Prepaid Expenses
Receivables $32.39M $35.79M
Other Receivables $0.00 $0.00
Total Short-Term Assets $205.7M $124.7M
YoY Change 64.93% -16.98%
LONG-TERM ASSETS
Property, Plant & Equipment $12.17M $10.82M
YoY Change 12.45% 17.78%
Goodwill $85.25M $88.77M
YoY Change -3.96% 107.64%
Intangibles
YoY Change
Long-Term Investments $3.600M $2.800M
YoY Change 28.57%
Other Assets $612.0K $2.315M
YoY Change -73.56% 132.66%
Total Long-Term Assets $170.1M $174.7M
YoY Change -2.65% 116.47%
TOTAL ASSETS
Total Short-Term Assets $205.7M $124.7M
Total Long-Term Assets $170.1M $174.7M
Total Assets $375.8M $299.4M
YoY Change 25.5% 29.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.385M $1.904M
YoY Change -27.26% -34.66%
Accrued Expenses $8.731M $9.728M
YoY Change -10.25% 40.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.63M $88.30M
YoY Change -5.29% 26.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $28.00M
YoY Change -100.0%
Other Long-Term Liabilities $1.060M $2.691M
YoY Change -60.61% 258.8%
Total Long-Term Liabilities $1.060M $30.69M
YoY Change -96.55% 3992.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.63M $88.30M
Total Long-Term Liabilities $1.060M $30.69M
Total Liabilities $84.69M $119.0M
YoY Change -28.83% 68.86%
SHAREHOLDERS EQUITY
Retained Earnings $3.092M -$4.308M
YoY Change -171.77% -72.16%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $282.1M $171.0M
YoY Change
Total Liabilities & Shareholders Equity $375.8M $299.4M
YoY Change 25.5% 29.65%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income $1.501M $2.722M
YoY Change -44.86% 39.73%
Depreciation, Depletion And Amortization $5.140M $3.253M
YoY Change 58.01% 35.49%
Cash From Operating Activities $5.710M $9.010M
YoY Change -36.63% -1.96%
INVESTING ACTIVITIES
Capital Expenditures $2.685M $2.313M
YoY Change 16.08% 109.51%
Acquisitions $88.08M
YoY Change 604.54%
Other Investing Activities -$20.00K -$79.92M
YoY Change -99.97% 978.54%
Cash From Investing Activities -$4.700M -$84.25M
YoY Change -94.42% 744.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -230.0K 28.02M
YoY Change -100.82% 9562.07%
NET CHANGE
Cash From Operating Activities 5.710M 9.010M
Cash From Investing Activities -4.700M -84.25M
Cash From Financing Activities -230.0K 28.02M
Net Change In Cash 780.0K -47.22M
YoY Change -101.65% 9344.0%
FREE CASH FLOW
Cash From Operating Activities $5.710M $9.010M
Capital Expenditures $2.685M $2.313M
Free Cash Flow $3.025M $6.697M
YoY Change -54.83% -17.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31729363 shares
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34764000
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31724000 shares
CY2016Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31724000 shares
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1659000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
282144000
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1060000
CY2016Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10285000
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
62038000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1385000
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
367000
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8731000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3092000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
375793000
CY2016Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4192000
CY2016Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
279066000
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
83634000
CY2016Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9821000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000
CY2016Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4763000
CY2016Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
26002000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
612000
CY2016Q1 us-gaap Prepaid Royalties
PrepaidRoyalties
15063000
CY2016Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
14074000
CY2016Q1 us-gaap Assets
Assets
375793000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32389000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12170000
CY2016Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
67690000
CY2016Q1 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1416000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
205722000
CY2016Q1 us-gaap Other Assets Current
OtherAssetsCurrent
6371000
CY2016Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
47200000
CY2016Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54366000
CY2016Q1 us-gaap Goodwill
Goodwill
85253000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82793000
CY2016Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3596000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81995000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31647000 shares
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31647000 shares
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3308000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
280320000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1058000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8685000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
65098000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4616000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
303000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7003000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1591000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
379569000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4350000
CY2015Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
278799000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
89078000
CY2015Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9053000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-70000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4763000
CY2015Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
24130000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
927000
CY2015Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
14036000
CY2015Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
13955000
CY2015Q4 us-gaap Assets
Assets
379569000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36348000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12471000
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
66976000
CY2015Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1998000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
209537000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8169000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
55966000
CY2015Q4 us-gaap Goodwill
Goodwill
83073000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82010000
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3640000
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
9007000
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28068000 shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
365000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27703000 shares
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.433 pure
CY2015Q1 us-gaap Payments For Software
PaymentsForSoftware
2023000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2313000
CY2015Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
7000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
2722000
CY2015Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
213000
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
47156000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-278000
CY2015Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
88075000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4790000
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
277000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2015Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
1945000
CY2015Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
21000
CY2015Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
19000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2743000
CY2015Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
21000
CY2015Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1049000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4799000
CY2015Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2077000
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6881000
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7347000
CY2015Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6927000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-47231000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-84253000
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
42366000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
28015000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4646000
CY2015Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
225000
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
25000
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
247000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
409000
CY2015Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
28000000
CY2015Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
9165000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2849000
CY2015Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-774000
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3253000
CY2015Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
20193000
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7000
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5712000
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
85000 shares
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001095565
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31666000 shares
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31970000 shares
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
304000 shares
CY2016Q1 dei Trading Symbol
TradingSymbol
HSTM
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.401 pure
CY2016Q1 us-gaap Payments For Software
PaymentsForSoftware
1990000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2685000
CY2016Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
41912000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
1501000
CY2016Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
288000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
54078000
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
500000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-789000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2487000
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-314000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000
CY2016Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
1027000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1557000
CY2016Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
56000
CY2016Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4451000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2505000
CY2016Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-233000
CY2016Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-43000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1004000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3218000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8557000
CY2016Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
7976000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
783000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4696000
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
51591000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-233000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7018000
CY2016Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
975000
CY2016Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
339000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2099000
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
55000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
CY2016Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
40916000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1879000
CY2016Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
768000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5140000
CY2016Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
22900000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
90000
CY2016Q1 hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan

Files In Submission

Name View Source Status
0001193125-16-572585-index-headers.html Edgar Link pending
0001193125-16-572585-index.html Edgar Link pending
0001193125-16-572585.txt Edgar Link pending
0001193125-16-572585-xbrl.zip Edgar Link pending
d137650d10q.htm Edgar Link pending
d137650dex311.htm Edgar Link pending
d137650dex312.htm Edgar Link pending
d137650dex321.htm Edgar Link pending
d137650dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hstm-20160331.xml Edgar Link completed
hstm-20160331.xsd Edgar Link pending
hstm-20160331_cal.xml Edgar Link unprocessable
hstm-20160331_def.xml Edgar Link unprocessable
hstm-20160331_lab.xml Edgar Link unprocessable
hstm-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending